On the heels of the announcement that the long-awaited VERITAS study has yielded positive results showing that our Virtual Exercise Rehabilitation Assistant (VERA™) virtual PT platform enables “a substantial reduction in post-acute costs and rehospitalizations while being as effective as traditional physical therapy,” Reflexion Health President and CEO Dr. Joseph “Joe” Smith has penned an article for STAT News describing the need for digital healthcare startups to commission such clinical trials.
“One of the big promises of digital health is the speed with which it can transform health care delivery,” Dr. Smith writes in the article. “But the full impact of digital health innovation is seen only with broad adoption of truly valuable solutions, and that rightfully requires evidence.”
Dr. Smith goes on to outline “the best way to gather that evidence” — i.e., via a “carefully conducted, prospective, randomized controlled trial.” He also describes in detail the challenges that digital healthcare startups face in achieving this important goal.
“Digital health companies must not shrink from demanding proof of value,” he concludes. “But we must also innovate the process of developing and disseminating such proof if we are to realize the full value of digital health.”